Cycloplegia in African-American children

Optometry and Vision Science

Volumn 76, Issue 2, 1999, Pages 102-107

  Kleinstein, Robert N ^a   Mutti, Donald O ^b,e   Manny, Ruth E ^c   Shin, Julie A ^d   Zadnik, Karla ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

African American children; Cyclopentolate; Cycloplegia; Mydriasis; Residual accommodation; Tropicamide

Indexed keywords

DRUG PRODUCTS; NITROGEN COMPOUNDS; PEDIATRICS; REFRACTOMETERS;

CYCLOPENTOLATE; CYCLOPLEGIA; MYDRIASIS; TROPICAMIDE;

OPHTHALMOLOGY;

CYCLOPENTOLATE; CYCLOPLEGIC AGENT; TROPICAMIDE;

ACCOMMODATION; ACCOMMODATION PARALYSIS; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG EFFICACY; EYE COLOR; EYE REFRACTION; FEMALE; HUMAN; MALE; MYDRIASIS; NEGRO; OPTOMETRY; PAIN; PRIORITY JOURNAL; PUPIL; TOPICAL DRUG ADMINISTRATION; VISION TEST;

EID: 0033083447     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006324-199902000-00017     Document Type: Article

References (30)

1. Zadnik K, Mutti DO, Friedman NE, Adams AJ. Initial cross-sectional results from the Orinda Longitudinal Study of Myopia. Optom Vis Sci 1993;70:750-8.
2. Egashira SM, Kish LL, Twelker JD, Mutti DO, Zadnik K, Adams AJ. Comparison of cyclopentolate vs. tropicamide cycloplegia in children. Optom Vis Sci 1993;70:1019-26.
3. Mutti DO, Zadnik K, Egashira S, Kish L, Twelker JD, Adams AJ. The effect of cycloplegia on measurement of the ocular components. Invest Ophthalmol Vis Sci 1994;35:515-27.
4. Milder B, Riffenburgh RS. An evaluation of cyclogyl (compound 75 GT). Am J Ophthalmol 1953;36:1724-6.
5. Merrill DL, Goldberg B, Zavell S. bis-Tropicamide, a new parasympatholytic. Curr Ther Res 1960;2:43-50.
6. Miranda MN. Residual accommodation. A comparison between cyclopentolate 1% and a combination of cyclopentolate 1% and tropicamide 1%. Arch Ophthalmol 1972;87:515-7.
7. Lovasik JV. Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide. Am J Optom Physiol Opt 1986;63:787-803.
8. Priestly BS, Medine MM. A new mydriatic and cycloplegic drug: compound 75 G.T. Am J Ophthalmol 1951;34:572-5.
9. Nishizawa AR, Orton RB, Cadera W. Comparison of 0.5% cyclopentolate plus 0.5% tropicamide and 1% cyclopentolate alone for mydriasis of dark irides. Can J Ophthalmol 1988;23:299-300.
10. Barbee RF, Smith WO. A comparative study of mydriatic and cycloplegic agents in human subjects without eye disease. Am J Ophthalmol 1957;44:617-22.
11. Cooper J Feldman JM, Jaanus SD, Appleman W, Appel S, Horn D. Pupillary dilation and funduscopy with 1.0% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) vs. tropicamide(0.5 or 1.0%) as a function of iris and skin pigmentation, and age. J Am Optom Assoc 1996;67:669-75.
12. Dillon JR, Tyhurst CW, Yolton RL. The mydriatic effect of tropicamide on light and dark irides. J Am Optom Assoc 1977;48:653-8.
13. Levine L. Tropicamide-induced mydriasis in densely pigmented eyes. Am J Optom Physiol Opt 1983;60:673-7.
14. Manny RE, Fern KD, Zervas HJ Cline GE, Scott SK, White JM, Pass AF. 1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response. Optom Vis Sci 1993;70:651-65.
15. Goldstein JH, Schneekloth BB. Atropine vs. cyclopentolate plus tropicamide in esodeviations. Ophthalmic Surg Lasers 1996;27: 1030-4.
16. Blum HL, Peters HB, Bettman JW. Vision Screening for Elementary Schools; The Orinda Study. Berkeley: University of California Press, 1959.
17. Mutti DO, Zadnik K, Adams AJ. A video technique for phakometry of the human crystalline lens. Invest Ophthalmol Vis Sci 1992;33: 1771-82.
18. Mark HH. Psychotogenic properties of cyclopentolate. JAMA 1963; 186:430-1.
19. Praeger DL, Miller SN. Toxic effects of cyclopentolate (cyclogel): [sic] report of a case. Am J Ophthalmol 1964;58:1060-1.
20. Adcock EW III. Cyclopentolate (Cyclogyl) toxicity in pediatric patients. J Pediatr 1971;79:127-9.
21. Awan KJ. Adverse systemic reactions of topical cyclopentolate hydrochloride. Ann Ophthalmol 1976;8:695-8.
22. Beswick JA. Psychosis from cyclopentolate. Am J Ophthalmol 1962; 53:879-80.
23. Binkhorst RD, Weinstein GW, Baretz RM, Clahane AC. Psychotic reaction induced by cyclopentolate (cyclogyl). Am J Ophthalmol 1963;55:1243-5.
24. Khurana AK, Ahluwalia BK, Rajan C, Vohra AK. Acute psychosis associated with topical cyclopentolate hydrochloride. Am J Ophthalmol 1988;105:91.
25. Zadnik K, Mutti DO, Adams AJ. The repeatability of measurement of the ocular components. Invest Ophthalmol Vis Sci 1992;33: 2325-33.
26. Gwiazda J Thorn F, Bauer J, Held R. Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci 1993;34:690-4.
27. Mutti DO, Zadnik K, Adams AJ. The equivalent refractive index of the crystalline lens in childhood. Vision Res 1995;35:1565-73.
28. Zadnik K, Satariano WA, Mutti DO, Sholtz RI, Adams AJ. The effect of parental history of myopia on children's eye size. JAMA 1994;271:1323-7.
29. Zadnik K, Mutti DO, Fusaro RE, Adams AJ. Longitudinal evidence of crystalline lens thinning in children. Invest Ophthalmol Vis Sci 1995;36:1581-7.
30. Mutti DO, Zadnik K, Fusaro RE, Friedman NE, Sholtz RI, Adams AJ. Optical and structural development of the crystalline lens in childhood. Invest Ophthalmol Vis Sci 1998;39:120-33.